Question 1

What is the Medicare GLP-1 Bridge program?

Accepted Answer

A temporary CMS demonstration (July 1, 2026 – December 31, 2027) that lets eligible people with Medicare drug coverage fill Wegovy, Zepbound (KwikPen), or Foundayo for a flat $50 a month. It runs nationally, outside your Part D plan, through a central processor administered by Humana.

Question 2

Who qualifies for the $50 GLP-1 program?

Accepted Answer

You need Medicare drug coverage plus one of three tiers: BMI 35+ alone; BMI 30+ with chronic kidney disease (stage 3a+), heart failure, or uncontrolled high blood pressure; or BMI 27+ with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease.

Question 3

How do I apply?

Accepted Answer

There is no patient application form. Your doctor submits a prior authorization to the program's central processor. Your job is to bring the right documentation to one appointment.

Question 4

Is $50 really the whole price?

Accepted Answer

Yes — $50 per monthly fill, no deductible, same price all year and in every state. The catches are different: the $50 doesn't count toward your Part D out-of-pocket cap, and Extra Help doesn't reduce it.

Question 5

I have type 2 diabetes. Am I eligible?

Accepted Answer

Not for the Bridge — but that's usually good news: Medicare already covers GLP-1s like Ozempic and Mounjaro for diabetes under standard Part D, where Extra Help applies and payments count toward the annual cap. Sleep apnea (moderate-to-severe) and MASH route the same way under their own indications.

Question 6

Which drugs are covered?

Accepted Answer

Three: Wegovy, Zepbound — in KwikPen form only, a rule that catches many people at the pharmacy — and Foundayo. All three cost the same $50 per monthly fill.

Question 7

Why was I quoted more than $50 at the pharmacy?

Accepted Answer

Almost always one of two things: the claim routed to your Part D plan instead of the Bridge's central processor, or a Zepbound prescription wasn't dispensed as KwikPen. Both are fixable at the counter.

Question 8

Does Extra Help / LIS lower the $50?

Accepted Answer

No. The program sits outside Part D, where Extra Help operates, so everyone pays the same $50. If you have Extra Help and a routing condition like diabetes, the standard Part D path may cost you less.

Question 9

Do I need to switch Medicare plans to use the program?

Accepted Answer

No — the Bridge works identically alongside every Part D and Medicare Advantage drug plan, with no plan opt-in. Never switch plans for this program; switch, if at all, for your other drugs' coverage.

Question 10

When does the program end?

Accepted Answer

December 31, 2027, with no announced extension or successor. We track extension signals weekly — and the honest planning advice is to start sooner rather than later and have an exit conversation with your prescriber.

Question 11

How much weight do people lose on these medications?

Accepted Answer

Trial averages: roughly 15% of body weight for Wegovy and up to about 20% for Zepbound at higher doses, over a year-plus alongside lifestyle changes. Individual results vary widely — your prescriber can set expectations for your situation.

Question 12

What are the side effects?

Accepted Answer

Mostly gastrointestinal — nausea, constipation, diarrhea — concentrated during dose increases and typically improving with time. The gradual dose-escalation schedules exist specifically to manage this.

Question 13

Can my BMI be measured at home for eligibility?

Accepted Answer

Use our calculator to see where you likely stand, but the measurement that counts is your provider's at the prior-authorization stage. If you're near a threshold (27, 30, or 35), get measured at your next visit.

Question 14

What counts as prediabetes, and why does everyone mention it?

Accepted Answer

An A1c of roughly 5.7–6.4%. It's the most common qualifying condition by far — about half of adults over 65 meet it, most without knowing — and it qualifies you at the program's lowest BMI tier (27+). One blood test settles it.

Question 15

My prior authorization was denied. Is that final?

Accepted Answer

Usually not — most denials trace to fixable documentation gaps (an undocumented condition, an outdated weight in the chart). Get the denial reason in writing and have your provider resubmit with corrected documentation.

Question 16

Does the program work if I spend winters in another state?

Accepted Answer

Yes — it's one of the most portable benefits in Medicare. The program runs nationally through one processor, so any participating pharmacy in any state fills at the same $50.

Question 17

Is there a cheaper way than $50?

Accepted Answer

Within the Bridge, no — and self-pay alternatives run several times higher. The only paths that can beat $50: the standard Part D route with Extra Help (if a routing condition applies to you), or state Medicaid coverage for some dual-eligibles.

Question 18

What happens to people mid-treatment when the program ends?

Accepted Answer

Unless CMS acts, fills after December 31, 2027 fall to other coverage or self-pay — so the exit-strategy conversation with your prescriber matters. Some patients will have developed routing diagnoses by then and move to Part D coverage.

Question 19

Is this website affiliated with Medicare or CMS?

Accepted Answer

No — we're a private, independent guide. Every program fact on this site is cited to CMS and KFF primary sources and stamped with the date we last verified it. For official information, visit Medicare.gov or call 1-800-MEDICARE.

Every question we get, answered

Jump to a question